Instrument Inactif

Autres langues Ekso Bionics Holdings Inc Deutsche Boerse AG

Actions

US2826441030

Cours en clôture Deutsche Boerse AG Autres places de cotation
- ^EUR	-

25/06	Ekso Bionics annonce un partenariat de recherche avec le Shepherd Center	CI
17/06	Ekso Bionics Holdings, Inc. nomme Deborah Lafer Scher à son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ekso Bionics Announces Research Partnership with Shepherd Center	25/06
Ekso Bionics Announces Research Partnership with Shepherd Center	25/06
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors	17/06
Ekso Bionics Holdings, Inc. Appoints Deborah Lafer Scher to its Board of Directors	17/06
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky	10/05
Ekso Bionics: Q1 Earnings Snapshot	29/04
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q1 Revenue $3.8M, vs. Street Est of $5M	29/04
Ekso Bionics Announces First Quarter 2024 Financial Results	29/04
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024	22/04
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal	12/04
Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Ekso Bionics: Q4 Earnings Snapshot	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04/03
Ekso Bionics Reports Record Annual Revenue of $18.3 Million	04/03
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024	26/02
Ekso Bionics Announces $4.6 Million Registered Direct Offering	11/01
Ekso Bionics Launches GaitCoach Software for EksoNR	08/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ekso Bionics Holdings Inc Deutsche Boerse AG

Actions

US2826441030

Autres langues

Filtres